Cite
A novel PPARγ agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways
MLA
Park, Ju-Young, et al. “A Novel PPARγ Agonist, KR62776, Suppresses RANKL-Induced Osteoclast Differentiation and Activity by Inhibiting MAP Kinase Pathways.” Biochemical & Biophysical Research Communications, vol. 378, no. 3, Jan. 2009, pp. 645–49. EBSCOhost, https://doi.org/10.1016/j.bbrc.2008.11.115.
APA
Park, J.-Y., Bae, M.-A., Cheon, H. G., Kim, S. S., Hong, J.-M., Kim, T.-H., Choi, J.-Y., Kim, S.-H., Lim, J., Choi, C.-H., Shin, H.-I., Kim, S.-Y., & Park, E. K. (2009). A novel PPARγ agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways. Biochemical & Biophysical Research Communications, 378(3), 645–649. https://doi.org/10.1016/j.bbrc.2008.11.115
Chicago
Park, Ju-Young, Myung-Ae Bae, Hyae Gyeong Cheon, Sung Soo Kim, Jung-Min Hong, Tae-Ho Kim, Je-Yong Choi, et al. 2009. “A Novel PPARγ Agonist, KR62776, Suppresses RANKL-Induced Osteoclast Differentiation and Activity by Inhibiting MAP Kinase Pathways.” Biochemical & Biophysical Research Communications 378 (3): 645–49. doi:10.1016/j.bbrc.2008.11.115.